Latest Federal Court Stories
Bernstein Liebhard LLP is currently representing Xarelto lawsuit plaintiffs whose cases are currently pending in the federal proceeding. New York, New York (PRWEB)
Bernstein Liebhard LLP is representing Lipitor Lawsuit plaintiffs in the federal proceeding, which involves allegations that the statin medication caused patients to develop new-onset Type 2 diabetes.
Bernstein Liebhard LLP looks forward to the April 21st conference, which will address the progress of discovery and other matters affecting federal testosterone lawsuits, including those filed
Bernstein Liebhard LLP, which is currently representing clients in the federal Lipitor proceeding, reports that the Court has granted Pfizer’s Motion, and has dismissed four individual Lipitor
Bernstein Liebhard LLP, which is currently representing a number of Xarelto plaintiffs in U.S.
Bernstein Liebhard is currently filing claims in federal court on behalf of individuals who allegedly suffered serious cardiovascular injuries due to the blood thinning medication.
The Firm is representing numerous plaintiffs whose Xarelto lawsuits are currently pending in federal court. New York, New York (PRWEB) February 26, 2015
The Firm is representing numerous Lipitor lawsuit plaintiffs in the federal litigation, and bellwether trials may provide insight into jury decisions in similar claims involving allegations that
The Firm is representing hundreds of clients in DePuy Pinnacle hip lawsuits that are currently pending in the federal litigation, and the outcomes of bellwether trials could portend jury decisions
- A serpent whose bite was fabled to produce intense thirst.